Issue
Alert me when new journal issues are available via or via
Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNFα levels during treatment Apostolia-Maria Tsimberidou, Tracey Waddelow, Hagop M Kantarjian, Maher Albitar, Francis J Giles pages 375-380 Abstract | Full Text | Full-Text PDF (70 KB)
Maternal and fetal outcomes in pregnancy complicated with acute leukemia: a single institutional experience with 10 pregnancies at 16 years Rıdvan Ali, Fahir Özkalemkaş, Tülay Özçelik, Vildan Özkocaman, Ülkü Ozan, Yalçın Kimya, Ahmet Tunalı pages 381-385 Abstract | Full Text | Full-Text PDF (106 KB)
The expression of PRAME in chronic lymphoproliferative disorders Rodrigo Proto-Siqueira, Roberto Passetto Falcão, Carmino Antonio de Souza, Sebastião José Ismael, Marco Antonio Zago pages 393-396 Abstract | Full Text | Full-Text PDF (81 KB)
The level of MEF but not ELF-1 correlates with FAB subtype of acute myeloid leukemia and is low in good prognosis cases Takuya Fukushima, Yasushi Miyazaki, Hideki Tsushima, Chizuko Tsutsumi, Jun Taguchi, Shinichiro Yoshida, Kazutaka Kuriyama, David Scadden, Stephen Nimer, Masao Tomonaga pages 387-392 Abstract | Full Text | Full-Text PDF (117 KB)
NOD/SCID mice transplanted with marrow from patients with myelodysplastic syndrome (MDS) show long-term propagation of normal but not clonal human precursors Ana I Benito, Eileen Bryant, Michael R Loken, George E Sale, Richard A Nash, M John Gass, H.Joachim Deeg pages 425-436 Abstract | Full Text | Full-Text PDF (443 KB)
Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals Corinna Strupp, Norbert Gattermann, Aristoteles Giagounidis, Carlo Aul, Barbara Hildebrandt, Rainer Haas, Ulrich Germing pages 397-404 Abstract | Full Text | Full-Text PDF (89 KB)
Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype Eloisi C Lopes, Mariana Garcia, Fernando Benavides, Jianjun Shen, Claudio J Conti, Elida Alvarez, Silvia E Hajos pages 413-423 Abstract | Full Text | Full-Text PDF (811 KB)
A randomized study comparing interferon (IFNα) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML) T. Kühr, S. Burgstaller, U. Apfelbeck, W. Linkesch, H. Seewann, M. Fridrik, G. Michlmayr, O. Krieger, D. Lutz, W. Lin, J. Pont, L. Köck, K. Abbrederis, C. Baldinger, R. Buder, D. Geissler, H. Hausmaninger, A. Lang, A. Zabernigg, C. Duba, W. Hilbe, W. Eisterer, M. Fiegl, R. Greil, G. Gastl, J. Thaler, for the Austrian CML Study Group pages 405-411 Abstract | Full Text | Full-Text PDF (269 KB)
In vitro culture of human acute lymphoblastic leukemia (ALL) cells in serum-free media; a comparison of native ALL blasts, ALL cell lines and virus-transformed B cell lines Øystein Bruserud, Nils Glenjen, Anita Ryningen, Elling Ulvestad pages 455-464 Abstract | Full Text | Full-Text PDF (108 KB)
Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells Sepideh Shaker, Mark Bernstein, Louise F Momparler, Richard L Momparler pages 437-444 Abstract | Full Text | Full-Text PDF (208 KB)
Inactivation of deoxycytidine kinase and overexpression of P-glycoprotein in AraC and daunorubicin double resistant leukemic cell lines Marjan J.T Veuger, M.Willy Honders, Hananja E Spoelder, Roel Willemze, Renée M.Y Barge pages 445-453 Abstract | Full Text | Full-Text PDF (176 KB)
Letter to the Editor
Waldenstrom’s macroglobulinemia: is there a place and time for a cease-fire? Pier Luigi Zinzani, Monica Tani, Lapo Alinari, Vittorio Stefoni, Michele Baccarani pages 465-466 Full Text | Full-Text PDF (119 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
